Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19

Hui Liu1,2, Jing Chen3,4, Qin Yang5

  • 1Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Med (New York, N.Y.)
|February 1, 2021
PubMed

Insights

A new PAWNN score, using complete blood count (CBC) parameters like platelet count and age, accurately predicts COVID-19 patient mortality. This simple tool aids clinicians in prioritizing care for critically ill patients.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Developing accurate prognostic tools for coronavirus disease 2019 (COVID-19) is crucial for patient management.
  • Complete blood count (CBC) parameters offer a readily available resource for risk stratification.

Purpose of the Study:

  • To develop and validate a sensitive risk score for predicting mortality in COVID-19 patients using CBC parameters.
  • To create a simple yet accurate tool to aid clinical decision-making.

Main Methods:

  • A retrospective cohort study involving 13,138 COVID-19 inpatients from China and Italy.
  • Generalized linear mixed models (GLMM) and Cox regression were used to identify predictors and construct the PAWNN score.
  • The score was validated using 10-fold cross-validation and independent cohorts.

Main Results:

  • The PAWNN score, incorporating platelet counts, age, white blood cell counts, neutrophil counts, and neutrophil:lymphocyte ratio, demonstrated high accuracy (AUROCs 0.92-0.97) in predicting mortality.
  • The score showed consistent performance across different patient subgroups and validation cohorts.
  • Latent Markov models confirmed the score's predictive power for disease progression.

Conclusions:

  • The PAWNN score is a validated, simple, and accurate tool for assessing COVID-19 patient mortality risk throughout hospitalization.
  • This risk assessment tool can assist clinicians in prioritizing treatment for COVID-19 patients, potentially improving outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
548
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
525
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.2K